Aidoc, a New York–based clinical AI company, has raised $150 million in a Series E funding round, bringing its total funding to over $500 million.
Investors
The round was led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures.
Growth Equity at Goldman Sachs Alternatives is part of Goldman Sachs Alternatives, a global investor in alternative assets managing over $625 billion in assets. The firm invests across private equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Since 2003, Growth Equity at Goldman Sachs Alternatives has invested more than $13 billion in growth-stage, technology-driven businesses across multiple industries. As of March 31, 2026, Goldman Sachs had approximately $3.7 trillion in assets under supervision globally.a
Aidoc Use of Funds
The company will use the funding to advance its clinical foundation model, CARE™, expand into additional medical indications, and scale the global deployment of its enterprise AI platform.
About Aidoc
Led by CEO Elad Walach, Aidoc is a clinical AI company focused on helping physicians make earlier, safer diagnoses by transforming raw patient data into actionable insights. The company is powered by its proprietary CARE™ foundation model and an enterprise AI platform, Aidoc aiOS™, embedding AI directly into clinical workflows. It enables health systems to deploy, manage, and scale multiple FDA-cleared solutions through a centralized operating layer. Headquartered in New York, Aidoc's technology is deployed across nearly 2,000 hospitals worldwide and processes tens of millions of patient cases annually.
Funding Details
Company: Aidoc
Raised: $150.0M
Round: Series E
Funding Date: April 2026
Lead Investor: Growth Equity at Goldman Sachs Alternatives
Additional Investors: General Catalyst, SoftBank Investment Advisors, NVentures
Company Website: https://www.aidoc.com/
Software Category: Healthcare AI / Clinical AI Platform
Source: https://www.prnewswire.com/news-releases/aidoc-raises-150-million-series-e-led-by-goldman-sachs-to-scale-clinical-ai-for-earlier-safer-diagnoses-302757181.html